Cargando…
Molecular profiling of signalling proteins for effects induced by the anti-cancer compound GSAO with 400 antibodies
BACKGROUND: GSAO (4-[N-[S-glutathionylacetyl]amino] phenylarsenoxide) is a hydrophilic derivative of the protein tyrosine phosphatase inhibitor phenylarsine oxide (PAO). It inhibits angiogenesis and tumour growth in mouse models and may be evaluated in a phase I clinical trial in the near future. In...
| Autores principales: | , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550423/ https://www.ncbi.nlm.nih.gov/pubmed/16764713 http://dx.doi.org/10.1186/1471-2407-6-155 |